Navigation Links
KGI Professor Cregg to Be Featured Speaker at Pichia 2012 Conference
Date:10/25/2011

CLAREMONT, Calif., Oct. 25, 2011 /PRNewswire/ -- Keck Graduate Institute (KGI) Research Professor James M. Cregg, PhD, will be the keynote speaker at the upcoming Pichia 2012 conference from February 23 – March 3 in Alpbach, Austria.

Cregg has spent years conducting internationally-renowned research on the development and use of the yeast species, Pichia pastoris, as a system for the production of recombinant proteins.

At the Pichia 2012 Conference he will discuss how the Pichia system began, how it works, and resources available to scientists and drug developers. The event is expected to attract a large audience of global participants from universities, research institutes and companies who wish to exchange ideas on Pichia.

Cregg's work has had a significant impact on the development of pharmaceutical proteins such as chimeric monoclonal antibodies, which work against rheumatoid arthritis, certain cancers and other diseases, as well as human serum albumen, a component of artificial blood plasma.

Many laboratories around the world now use Pichia to make proteins for medical and research applications. Expectations are that within the next decade this yeast expression system will lead to the development of more drugs to combat diseases, according to Cregg.

Cregg has provided keynote addresses at numerous meetings. He serves as a reviewer or editor on five peer-reviewed journals in the biotechnology field: Protein Expression and Purification (executive editor); Applied and Environmental Microbiology; Biotechnology Letters; FEMS Yeast Research; and Molecular Biotechnology.

For more information on the Pichia 2012 conference, visit www.pichia2012.com.

KGI BACKGROUND

Educating the future leaders of the bioscience industry, Keck Graduate Institute (KGI) offers an interdisciplinary graduate education t
'/>"/>

SOURCE Keck Graduate Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. KGI Professor Awarded Patent for Stem-Cell Therapy Aiding Heart-attack Patients
2. Nature offers key lessons on harvesting solar power, says U of T chemistry professor
3. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
4. INRS professor Federico Rosei awarded Rutherford Memorial Medal for Chemistry
5. UT professors pathogen research inspires robotics design for medicine and military
6. UCSB professor receives Presidential Green Chemistry Challenge Award
7. Enhanced electrical energy storage may result from professors research
8. NJIT professor develops a biologically inspired catalyst, an active yet inert material
9. Engineering professor wins award for pioneering work expected to improve electronic devices
10. Grove School professor leads new metamaterials center
11. Queens University professor uses nanotechnology to prolong machine and engine life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... DUBLIN , July 24, 2014 ... the "Global Cell Culture Market 2014-2018" report ... Cell culture is the in vitro ... such as research, cell studies, and biopharmaceutical production. Cell ... vaccine production. Cell culture instruments and cell culture consumables ...
(Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
(Date:7/24/2014)...  CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical ... for the prevention and treatment of cardiorenal and ... July 18, 2014 from the NYSE MKT LLC ... plan to regain compliance with continued listing standards ... is continuing the Company,s listing and has granted ...
(Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2Getting More Life out of Lithium-ion Batteries 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
... , , ROCKVILLE, Md., ... has announced that 263 regulatory professionals achieved Regulatory Affairs ... RAC credential is administered by RAPS and is the ... product sector. , , (Logo: ...
... BEIJING, Sept. 4 /PRNewswire-Asia/ -- ... provider of biopharmaceutical products in China, announced today that,the ... Republic,of China has issued the initial order to Sinovac ... to the initial order, Sinovac is,required to complete the ...
... September 4 Karolinska Development (publ),today announced that one ... clinical study of its candidate drug, tafoxiparin, a,new drug ... promising results of the Phase II trial bring the ... strategy. , Dilafor,s candidate drug, ...
Cached Biology Technology:263 Regulatory Professionals Achieve RAC Certification 2263 Regulatory Professionals Achieve RAC Certification 3Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 2Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 3Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial 2Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial 3
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, ... from the long-term, randomized, active control Phase 3 study ... iron-based phosphate binder, for the treatment of hyperphosphatemia in ... PERFECTED study (PhosphatE binding and iRon delivery with FErric ... Journal of the American Society of Nephrology ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... Hopkins scientists seems to have discovered an almost-too-easy way to ... potent versions. Their finding, reported this week in Nature, could ... but also other body tissues. What the researchers ... neural stem cells the sort that might be used ...
... The giant panda is not at an evolutionary dead end ... new research involving scientists from Cardiff University. Previous ... requirements and slow reproductive rates have led to a lack ... extinction. Now a study by Professor Michael Bruford ...
... August 23, 2007 On August 16, the Food and ... sold under the brand name Coumadin. The new label suggests ... be safer for patients with variations in two genes, CYP2C9 ... testing, which may be a useful tool in determining appropriate ...
Cached Biology News:When is a stem cell not really a stem cell? 2American College of Medical Genetics responds to new FDA labeling decision for warfarin 2
Request Info...
supplied with 10x reaction buffer...
... from yeast/leuconostoc overproducer ATP: ... EC 2.7.1.1/1.1.1.49. One unit of ... of D-glucose in 1 min ... One unit of G6P-DH will ...
Request Info...
Biology Products: